Zhejiang NHU Company (002001) Q4 2024 earnings summary

Executive summary

• Operating revenue reached RMB 21.61 billion in 2024, up 42.95% year-over-year, with net profit attributable to shareholders at RMB 5.87 billion, a 117.01% increase year-over-year.

• Growth was driven by expanded production capacity, especially in amino acids and methionine, and improved market prices for key nutrition products.

• The company maintained its focus on nutrition, flavor and fragrance, new polymer materials, and APIs, with significant R&D investment and global expansion.

Financial highlights

• Net profit after deducting non-recurring items was RMB 5.83 billion, up 122.97% year-over-year.

• Gross margin improved across major segments, with nutrition gross margin up 13.27 percentage points year-over-year.

• Net cash flows from operating activities increased 38.16% to RMB 7.07 billion.

• Basic and diluted EPS were both RMB 1.91, up from RMB 0.87 in 2023.

• Total assets grew 9.79% to RMB 42.99 billion; net assets attributable to shareholders rose 18.22% to RMB 29.32 billion.

Outlook and guidance

• The company will continue its integration, serialization, and synergy strategy, focusing on “Chemical +” and “Bio +” platforms.

• Plans include accelerating overseas expansion, enhancing innovation, and strengthening risk management.

• Key focus areas are expanding nutrition, diversifying flavor and fragrance, scaling new materials, and refining APIs.